Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Incidence and mortality of moderate and severe traumatic brain injury in children: A ten year population-based cohort study in Norway.

Olsen M, Vik A, Lund Nilsen TI, Uleberg O, Moen KG, Fredriksli O, Lien E, Finnanger TG, Skandsen T.

Eur J Paediatr Neurol. 2019 Mar 4. pii: S1090-3798(18)30389-1. doi: 10.1016/j.ejpn.2019.01.009. [Epub ahead of print]

PMID:
30879962
2.

The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes.

Hansen TV, Vik A, Serhan CN.

Front Pharmacol. 2019 Jan 17;9:1582. doi: 10.3389/fphar.2018.01582. eCollection 2018. Review.

3.

Diffusion kurtosis imaging in mild traumatic brain injury and postconcussional syndrome.

Karlsen RH, Einarsen C, Moe HK, Håberg AK, Vik A, Skandsen T, Eikenes L.

J Neurosci Res. 2019 May;97(5):568-581. doi: 10.1002/jnr.24383. Epub 2019 Jan 24.

PMID:
30675907
4.

Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA.

Tungen JE, Gerstmann L, Vik A, De Matteis R, Colas RA, Dalli J, Chiang N, Serhan CN, Kalesse M, Hansen TV.

Chemistry. 2019 Jan 28;25(6):1476-1480. doi: 10.1002/chem.201806029. Epub 2018 Dec 20.

PMID:
30511787
5.

Synthetic manipulations of polyunsaturated fatty acids as a convenient strategy for the synthesis of bioactive compounds.

Vik A, Hansen TV.

Org Biomol Chem. 2018 Dec 12;16(48):9319-9333. doi: 10.1039/c8ob02586j. Review.

PMID:
30511071
6.

Time of Injury and Relation to Alcohol Intoxication in Moderate-to-Severe Traumatic Brain Injury: A Decade-Long Prospective Study.

Bjarkø VV, Skandsen T, Moen KG, Gulati S, Helseth E, Nilsen TIL, Vik A.

World Neurosurg. 2019 Feb;122:e684-e689. doi: 10.1016/j.wneu.2018.10.122. Epub 2018 Oct 30.

7.

Disrupted Synthesis of a Di-N-acetylated Sugar Perturbs Mature Glycoform Structure and Microheterogeneity in the O-Linked Protein Glycosylation System of Neisseria elongata subsp. glycolytica.

Wang N, Anonsen JH, Viburiene R, Lam JS, Vik Å, Koomey M.

J Bacteriol. 2018 Dec 7;201(1). pii: e00522-18. doi: 10.1128/JB.00522-18. Print 2019 Jan 1.

PMID:
30322851
8.

Synthesis and biological evaluations of marine oxohexadecenoic acids: PPARα/γ dual agonism and anti-diabetic target gene effects.

Sæther T, Paulsen SM, Tungen JE, Vik A, Aursnes M, Holen T, Hansen TV, Nebb HI.

Eur J Med Chem. 2018 Jul 15;155:736-753. doi: 10.1016/j.ejmech.2018.06.034. Epub 2018 Jun 18.

9.

Synthesis, molecular modelling studies and biological evaluation of new oxoeicosanoid receptor 1 agonists.

Stepniewski TM, Torrens-Fontanals M, Rodríguez-Espigares I, Giorgino T, Primdahl KG, Vik A, Stenstrøm Y, Selent J, Hansen TV.

Bioorg Med Chem. 2018 Jul 23;26(12):3580-3587. doi: 10.1016/j.bmc.2018.05.036. Epub 2018 May 23.

PMID:
29866479
10.

PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function.

Pistorius K, Souza PR, De Matteis R, Austin-Williams S, Primdahl KG, Vik A, Mazzacuva F, Colas RA, Marques RM, Hansen TV, Dalli J.

Cell Chem Biol. 2018 Jun 21;25(6):749-760.e9. doi: 10.1016/j.chembiol.2018.04.017. Epub 2018 May 24.

11.

Synthesis, molecular modeling and biological evaluation of potent analogs of 2-methoxyestradiol.

Al-Kazaale N, Tran PT, Haidari F, Solum EJ, Liekens S, Vervaeke P, Sylte I, Cheng JJ, Vik A, Hansen TV.

Steroids. 2018 Aug;136:47-55. doi: 10.1016/j.steroids.2018.05.002. Epub 2018 May 18.

PMID:
29772242
12.

Frequency and prognostic factors of olfactory dysfunction after traumatic brain injury.

Bratt M, Skandsen T, Hummel T, Moen KG, Vik A, Nordgård S, Helvik AS.

Brain Inj. 2018;32(8):1021-1027. doi: 10.1080/02699052.2018.1469043. Epub 2018 May 9.

PMID:
29741969
13.

The epidemiology of mild traumatic brain injury: the Trondheim MTBI follow-up study.

Skandsen T, Einarsen CE, Normann I, Bjøralt S, Karlsen RH, McDonagh D, Nilsen TL, Akslen AN, Håberg AK, Vik A.

Scand J Trauma Resusc Emerg Med. 2018 Apr 27;26(1):34. doi: 10.1186/s13049-018-0495-0.

14.

Moderate Traumatic Brain Injury: Clinical Characteristics and a Prognostic Model of 12-Month Outcome.

Einarsen CE, van der Naalt J, Jacobs B, Follestad T, Moen KG, Vik A, Håberg AK, Skandsen T.

World Neurosurg. 2018 Jun;114:e1199-e1210. doi: 10.1016/j.wneu.2018.03.176. Epub 2018 Mar 31.

15.

Patients with Moderate and Severe Traumatic Brain Injury: Impact of Preinjury Platelet Inhibitor or Warfarin Treatment.

Tollefsen MH, Vik A, Skandsen T, Sandrød O, Deane SF, Rao V, Moen KG.

World Neurosurg. 2018 Jun;114:e209-e217. doi: 10.1016/j.wneu.2018.02.167. Epub 2018 Mar 7.

16.

Headache following head injury: a population-based longitudinal cohort study (HUNT).

Nordhaug LH, Hagen K, Vik A, Stovner LJ, Follestad T, Pedersen T, Gravdahl GB, Linde M.

J Headache Pain. 2018 Jan 22;19(1):8. doi: 10.1186/s10194-018-0838-2.

17.

The Influence of Traumatic Axonal Injury in Thalamus and Brainstem on Level of Consciousness at Scene or Admission: A Clinical Magnetic Resonance Imaging Study.

Moe HK, Moen KG, Skandsen T, Kvistad KA, Laureys S, Håberg A, Vik A.

J Neurotrauma. 2018 Feb 9. doi: 10.1089/neu.2017.5252. [Epub ahead of print]

18.

Do patients consult their GP for sexual concerns? A cross sectional explorative study.

Vik A, Brekke M.

Scand J Prim Health Care. 2017 Dec;35(4):373-378. doi: 10.1080/02813432.2017.1398934. Epub 2017 Nov 6.

19.

Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA.

Primdahl KG, Tungen JE, De Souza PRS, Colas RA, Dalli J, Hansen TV, Vik A.

Org Biomol Chem. 2017 Oct 18;15(40):8606-8613. doi: 10.1039/c7ob02113e.

PMID:
28980694
20.

Serum osteoprotegerin and renal function in the general population: the Tromsø Study.

Vik A, Brodin EE, Mathiesen EB, Brox J, Jørgensen L, Njølstad I, Brækkan SK, Hansen JB.

Clin Kidney J. 2017 Feb;10(1):38-44. doi: 10.1093/ckj/sfw095. Epub 2016 Oct 3.

21.

Regioselective monoalkylation of 17β-estradiol for the synthesis of cytotoxic estrogens.

Gansbeke KV, Solum EJ, Liekens S, Vik A, Hansen TV.

Steroids. 2017 Aug;124:54-59. doi: 10.1016/j.steroids.2017.06.001. Epub 2017 Jun 15.

PMID:
28624547
22.

Structural and genetic analyses of glycan O-acetylation in a bacterial protein glycosylation system: evidence for differential effects on glycan chain length.

Anonsen JH, Børud B, Vik Å, Viburiene R, Koomey M.

Glycobiology. 2017 Sep 1;27(9):888-899. doi: 10.1093/glycob/cwx032.

PMID:
28460017
23.

Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid.

Vik A, Dalli J, Hansen TV.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2259-2266. doi: 10.1016/j.bmcl.2017.03.079. Epub 2017 Mar 31. Review.

PMID:
28408222
24.

Myocardial infarction and future risk of cancer in the general population-the Tromsø Study.

Rinde LB, Småbrekke B, Hald EM, Brodin EE, Njølstad I, Mathiesen EB, Løchen ML, Wilsgaard T, Brækkan SK, Vik A, Hansen JB.

Eur J Epidemiol. 2017 Mar;32(3):193-201. doi: 10.1007/s10654-017-0231-5. Epub 2017 Feb 7.

PMID:
28176141
25.

Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins.

Primdahl KG, Aursnes M, Walker ME, Colas RA, Serhan CN, Dalli J, Hansen TV, Vik A.

J Nat Prod. 2016 Oct 28;79(10):2693-2702. Epub 2016 Oct 5.

26.

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.

Småbrekke B, Rinde LB, Hindberg K, Hald EM, Vik A, Wilsgaard T, Løchen ML, Njølstad I, Mathiesen EB, Hansen JB, Brækkan S.

PLoS One. 2016 Sep 16;11(9):e0163242. doi: 10.1371/journal.pone.0163242. eCollection 2016.

27.

A Retrospective Comparison of Ultrasound-Assisted Catheter-Directed Thrombolysis and Catheter-Directed Thrombolysis Alone for Treatment of Proximal Deep Vein Thrombosis.

Tichelaar VY, Brodin EE, Vik A, Isaksen T, Skjeldestad FE, Kumar S, Trasti NC, Singh K, Hansen JB.

Cardiovasc Intervent Radiol. 2016 Aug;39(8):1115-21. doi: 10.1007/s00270-016-1367-5. Epub 2016 Jun 1.

28.

Moderate traumatic brain injury, acute phase course and deviations in physiological variables: an observational study.

Lund SB, Gjeilo KH, Moen KG, Schirmer-Mikalsen K, Skandsen T, Vik A.

Scand J Trauma Resusc Emerg Med. 2016 May 23;24:77. doi: 10.1186/s13049-016-0269-5.

29.

Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.

Rinde LB, Lind C, Småbrekke B, Njølstad I, Mathiesen EB, Wilsgaard T, Løchen ML, Hald EM, Vik A, Braekkan SK, Hansen JB.

J Thromb Haemost. 2016 Jun;14(6):1183-91. doi: 10.1111/jth.13329. Epub 2016 May 10.

30.

Inter-rater agreement between professional-rated and patient-rated scores of the Villalta scale for evaluation of the post-thrombotic syndrome.

Isaksen T, Tichelaar YI, Skjeldestad FE, Brodin EE, Vik A, Singh K, Hansen JB.

Thromb Res. 2016 May;141:175-7. doi: 10.1016/j.thromres.2016.03.027. Epub 2016 Mar 26. No abstract available.

PMID:
27058275
31.

Traumatic axonal injury: Relationships between lesions in the early phase and diffusion tensor imaging parameters in the chronic phase of traumatic brain injury.

Moen KG, Vik A, Olsen A, Skandsen T, Håberg AK, Evensen KA, Eikenes L.

J Neurosci Res. 2016 Jul;94(7):623-35. doi: 10.1002/jnr.23728. Epub 2016 Mar 6.

PMID:
26948154
32.

Synthesis of 5-(S)-HETE, 5-(S)-HEPE and (+)-zooxanthellactone: Three hydroxylated polyunsaturated fatty acid metabolites.

Primdahl KG, Stenstrøm Y, Hansen TV, Vik A.

Chem Phys Lipids. 2016 Mar;196:1-4. doi: 10.1016/j.chemphyslip.2015.12.005. Epub 2016 Jan 29.

PMID:
26828369
33.

Synthesis of 5-trifluoromethyl-2-sulfonylpyridine PPARβ/δ antagonists: Effects on the affinity and selectivity towards PPARβ/δ.

Kaupang Å, Kase ET, Vo CX, Amundsen M, Vik A, Hansen TV.

Bioorg Med Chem. 2016 Jan 15;24(2):247-60. doi: 10.1016/j.bmc.2015.12.012. Epub 2015 Dec 10.

PMID:
26707845
34.

Headaches in patients with previous head injuries: A population-based historical cohort study (HUNT).

Hoem Nordhaug L, Vik A, Hagen K, Stovner LJ, Pedersen T, Gravdahl GB, Linde M.

Cephalalgia. 2016 Oct;36(11):1009-1019. doi: 10.1177/0333102415618948. Epub 2016 Jul 19.

PMID:
26634833
35.

Life after Adolescent and Adult Moderate and Severe Traumatic Brain Injury: Self-Reported Executive, Emotional, and Behavioural Function 2-5 Years after Injury.

Finnanger TG, Olsen A, Skandsen T, Lydersen S, Vik A, Evensen KA, Catroppa C, Håberg AK, Andersson S, Indredavik MS.

Behav Neurol. 2015;2015:329241. doi: 10.1155/2015/329241. Epub 2015 Oct 13.

36.

Intracranial Pressure During Pressure Control and Pressure-Regulated Volume Control Ventilation in Patients with Traumatic Brain Injury: A Randomized Crossover trial.

Schirmer-Mikalsen K, Vik A, Skogvoll E, Moen KG, Solheim O, Klepstad P.

Neurocrit Care. 2016 Jun;24(3):332-41. doi: 10.1007/s12028-015-0208-8.

PMID:
26503512
37.

Characterization of a Unique Tetrasaccharide and Distinct Glycoproteome in the O-Linked Protein Glycosylation System of Neisseria elongata subsp. glycolytica.

Anonsen JH, Vik Å, Børud B, Viburiene R, Aas FE, Kidd SW, Aspholm M, Koomey M.

J Bacteriol. 2015 Oct 19;198(2):256-67. doi: 10.1128/JB.00620-15. Print 2016 Jan 15.

38.

Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol.

Solum EJ, Akselsen ØW, Vik A, Hansen TV.

Curr Pharm Des. 2015;21(38):5453-66. Review.

PMID:
26429718
39.

Fractional anisotropy shows differential reduction in frontal-subcortical fiber bundles-A longitudinal MRI study of 76 middle-aged and older adults.

Vik A, Hodneland E, Haász J, Ystad M, Lundervold AJ, Lundervold A.

Front Aging Neurosci. 2015 May 15;7:81. doi: 10.3389/fnagi.2015.00081. eCollection 2015.

40.

[Equitable access to medication].

Leiten EO, Vikan IM, Vik A, Årstøl E.

Tidsskr Nor Laegeforen. 2015 Apr 21;135(7):634. doi: 10.4045/tidsskr.15.0110. eCollection 2015 Apr 21. Norwegian. No abstract available.

41.

An efficient total synthesis of leukotriene B4.

Primdahl KG, Tungen JE, Aursnes M, Hansen TV, Vik A.

Org Biomol Chem. 2015 May 21;13(19):5412-7. doi: 10.1039/c5ob00473j.

PMID:
25857248
42.

White matter microstructure in chronic moderate-to-severe traumatic brain injury: Impact of acute-phase injury-related variables and associations with outcome measures.

Håberg AK, Olsen A, Moen KG, Schirmer-Mikalsen K, Visser E, Finnanger TG, Evensen KA, Skandsen T, Vik A, Eikenes L.

J Neurosci Res. 2015 Jul;93(7):1109-26. doi: 10.1002/jnr.23534. Epub 2014 Dec 30.

PMID:
25641684
43.

Red cell distribution width and carotid atherosclerosis progression. The Tromsø Study.

Lappegård J, Ellingsen TS, Vik A, Skjelbakken T, Brox J, Mathiesen EB, Johnsen SH, Brækkan SK, Hansen JB.

Thromb Haemost. 2015 Mar;113(3):649-54. doi: 10.1160/TH14-07-0606. Epub 2015 Jan 29.

PMID:
25631329
44.

Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study.

Vik A, Brodin EE, Mathiesen EB, Brox J, Jørgensen L, Njølstad I, Brækkan SK, Hansen JB.

Eur J Epidemiol. 2015 Mar;30(3):219-30. doi: 10.1007/s10654-014-9975-3. Epub 2014 Dec 2.

PMID:
25446307
45.

Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings.

Rundhaug NP, Moen KG, Skandsen T, Schirmer-Mikalsen K, Lund SB, Hara S, Vik A.

J Neurosurg. 2015 Jan;122(1):211-8. doi: 10.3171/2014.9.JNS14322.

PMID:
25361494
46.

Cytochrome c-based domain modularity governs genus-level diversification of electron transfer to dissimilatory nitrite reduction.

Aas FE, Li X, Edwards J, Hongrø Solbakken M, Deeudom M, Vik Å, Moir J, Koomey M, Aspholm M.

Environ Microbiol. 2015 Jun;17(6):2114-32. doi: 10.1111/1462-2920.12661. Epub 2014 Dec 11.

PMID:
25330335
47.

Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1.

Tungen JE, Aursnes M, Vik A, Ramon S, Colas RA, Dalli J, Serhan CN, Hansen TV.

J Nat Prod. 2014 Oct 24;77(10):2241-7. doi: 10.1021/np500498j. Epub 2014 Sep 23.

48.

Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis.

Solum EJ, Cheng JJ, Sørvik IB, Paulsen RE, Vik A, Hansen TV.

Eur J Med Chem. 2014 Oct 6;85:391-8. doi: 10.1016/j.ejmech.2014.08.002. Epub 2014 Aug 2.

PMID:
25108078
49.

Prospective longitudinal MRI study of brain volumes and diffusion changes during the first year after moderate to severe traumatic brain injury.

Brezova V, Moen KG, Skandsen T, Vik A, Brewer JB, Salvesen O, Håberg AK.

Neuroimage Clin. 2014 Mar 28;5:128-40. doi: 10.1016/j.nicl.2014.03.012. eCollection 2014.

50.

Synthesis, cytotoxic effects and tubulin polymerization inhibition of 1,4-disubstituted 1,2,3-triazole analogs of 2-methoxyestradiol.

Solum EJ, Vik A, Hansen TV.

Steroids. 2014 Sep;87:46-53. doi: 10.1016/j.steroids.2014.05.020. Epub 2014 Jun 9.

PMID:
24923521

Supplemental Content

Support Center